• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Inogen Inc

    3/27/25 8:03:28 AM ET
    $INGN
    Industrial Specialties
    Health Care
    Get the next $INGN alert in real time by email
    DEFA14A 1 ingn_2025_defa_14a.htm DEFA14A DEFA14A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

    PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE

    SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. )

    Filed by the Registrant x

     

    Filed by a Party other than the Registrant o

     

    Check the appropriate box:

    o Preliminary Proxy Statement

    o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2))

    o Definitive Proxy Statement

    x Definitive Additional Materials

    o Soliciting Material Pursuant to §240.14a-12

    Inogen, Inc.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    x No fee required.

    o Fee paid previously with preliminary materials

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     

     


     

    img44022822_0.jpg

     

    Your Vote Counts! INOGEN, INC. 2025 Annual Meeting Vote by May 13, 2025 11:59 PM ET. For shares held in a Plan, vote by May 7, 2025 11:59 PM ET. INOGEN, INC. 859 WARD DRIVE, SUITE 200 GOLETA, CA 93111 V67695-P23276 You invested in INOGEN, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on May 14, 2025. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 30, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote Virtually at the Meeting* May 14, 2025 10:00 AM PDT Virtually at: www.virtualshareholdermeeting.com/INGN2025 *Please check the meeting materials for any special requirements for meeting attendance.


     

    img44022822_1.jpg

     

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is only an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Voting Items Board Recommends 1. Election of Class II Directors For Nominees: 01) Kevin King 02) Mary Kay Ladone 03) Kevin R.M. Smith 2. To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2025. For 3. To approve, on an advisory and non-binding basis, the compensation of our named executive officers. For 4. To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. For Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V67696-P23276


    Get the next $INGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $INGN

    DatePrice TargetRatingAnalyst
    6/16/2025$14.00Buy
    B. Riley Securities
    5/22/2025$12.00Hold → Buy
    Needham
    2/15/2024Mkt Perform → Outperform
    William Blair
    8/8/2023$15.00 → $8.00Overweight → Neutral
    JP Morgan
    7/14/2023Buy → Hold
    Needham
    1/17/2023Outperform → Mkt Perform
    William Blair
    12/9/2021$47.00Hold → Buy
    Needham
    11/8/2021$70.00 → $40.00Hold
    Stifel
    More analyst ratings

    $INGN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Inogen Announces First Quarter 2025 Financial Results

      Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2025. "Inogen's strong first quarter financial results underscore our success in driving improved commercial and operational execution," said Kevin Smith, President and Chief Executive Officer. "We are making great progress and remain committed to positioning the company for sustainable growth and profitability, while creating value for all stakeholders." First Quarter 2025 Financial Results Total revenue in the first quarter of 2025 was $82.3 million, an increase of 5.5% from the prior-year p

      5/7/25 4:05:00 PM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen to Report First Quarter 2025 Financial Results on May 7, 2025

      Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. On the same day, the Company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Non-US callers (201) 689-8589 Please reference Inogen to join the call. A live audio webcast and archived recording of the conference call will be available to all interested parties through the News / Events page on the Inogen Investo

      4/16/25 8:30:00 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

      Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 24th Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 8:45 a.m. Eastern Time. A live audio webcast and archived recording of the presentation will be available to all interested parties through the News / Events page on the Inogen Investor Relations website. Inogen has used, and intends to continue to use, its Investor Relations website,

      3/20/25 8:30:00 AM ET
      $INGN
      Industrial Specialties
      Health Care

    $INGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, CFO & Treasurer Bourque Michael J. was granted 48,225 shares, converted options into 25,000 shares, covered exercise/tax liability with 28,579 shares and bought $24,960 worth of shares (3,000 units at $8.32) (SEC Form 4)

      4 - Inogen Inc (0001294133) (Issuer)

      3/4/25 6:42:36 PM ET
      $INGN
      Industrial Specialties
      Health Care
    • CEO and President Smith Kevin Raymond Merrill was granted 55,475 shares, converted options into 28,333 shares, covered exercise/tax liability with 39,797 shares and bought $100,245 worth of shares (11,709 units at $8.56), increasing direct ownership by 383% to 70,274 units (SEC Form 4)

      4 - Inogen Inc (0001294133) (Issuer)

      3/4/25 6:41:11 PM ET
      $INGN
      Industrial Specialties
      Health Care

    $INGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • B. Riley Securities initiated coverage on Inogen with a new price target

      B. Riley Securities initiated coverage of Inogen with a rating of Buy and set a new price target of $14.00

      6/16/25 7:50:27 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen upgraded by Needham with a new price target

      Needham upgraded Inogen from Hold to Buy and set a new price target of $12.00

      5/22/25 8:16:14 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Inogen upgraded by William Blair

      William Blair upgraded Inogen from Mkt Perform to Outperform

      2/15/24 6:28:38 AM ET
      $INGN
      Industrial Specialties
      Health Care

    $INGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Boehnlein Glenn S was granted 30,612 shares, increasing direct ownership by 66% to 76,885 units (SEC Form 4)

      4 - Inogen Inc (0001294133) (Issuer)

      5/19/25 8:53:23 AM ET
      $INGN
      Industrial Specialties
      Health Care
    • Director Rider Heather D. was granted 30,612 shares, increasing direct ownership by 53% to 88,201 units (SEC Form 4)

      4 - Inogen Inc (0001294133) (Issuer)

      5/16/25 7:42:08 PM ET
      $INGN
      Industrial Specialties
      Health Care
    • Director Sahney Mira Kirti was granted 30,612 shares, increasing direct ownership by 336% to 39,724 units (SEC Form 4)

      4 - Inogen Inc (0001294133) (Issuer)

      5/16/25 7:41:29 PM ET
      $INGN
      Industrial Specialties
      Health Care